C-Path
ActiveSummary
The computed 12-month bankruptcy probability of C-Path is 1.7% (moderate). The 2025 annual accounts show negative equity (-€287,620) and a net result of -€537,258. Equity is shrinking by about 40% per year across the filed financial years. Its solvency ranks better than 9% of 3,311 sector peers (NACE 62, financial year 2025). The company has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
24-09
Gazette deed
Resignation: Life Sciences Consulting bv (director)Permanent representatives: Kris Motmans and Joris Pieter De Gussem · Appointment: De Sasmeester CommV (director) · Power of attorney6 facts ▸
- General meeting, 29-08-2025
- Director resignation, Life Sciences Consulting bv (director)
- Permanent representative, Kris Motmans
- Director appointment, De Sasmeester CommV (director)
- Permanent representative, Joris Pieter De Gussem
- Power of attorney, OneCo bv
05-08
Gazette deed
MiscellaneousAuditor report · Capital increase · Capital contribution11 facts ▸
- General meeting, 27-06-2025
- Auditor report, “Sint-Truiden, geen bevindingen van materieel belang” (deed in Dutch)
- Other provision, “kennisname bijzonder verslag bestuursorgaan, vergadering neemt kennis van door wet vereist bijzonder verslag” (deed in Dutch)
- Other provision, “neerlegging verslagen, samen neer te leggen” (deed in Dutch)
- Capital increase, €858,685.87
- Capital contribution
- Share issue, “aandelen op naam zonder nominale waarde”, 858685 (deed in Dutch)
- Shareholding, “op naam zonder nominale waarde”, 858685 (deed in Dutch)
- Capital contribution, €858,685.87
- Amendment of the articles, “Artikel 5” (deed in Dutch)
- Power of attorney, Phil VANHAEREN
About the unread acts
Of the 5 Belgian Official Gazette deeds we know for this company, 2 have been read. The other 3 have not been read yet: what they contain is neither established nor disproved here.